Eleanor J. Cheadle

3.6k total citations · 1 hit paper
35 papers, 2.7k citations indexed

About

Eleanor J. Cheadle is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Eleanor J. Cheadle has authored 35 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Eleanor J. Cheadle's work include Immunotherapy and Immune Responses (20 papers), CAR-T cell therapy research (19 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Eleanor J. Cheadle is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), CAR-T cell therapy research (19 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Eleanor J. Cheadle collaborates with scholars based in United Kingdom, United States and Netherlands. Eleanor J. Cheadle's co-authors include Tim Illidge, Jamie Honeychurch, Simon J. Dovedi, Robert W. Wilkinson, David E. Gilham, Edmund Poon, Michelle Morrow, Ross Stewart, Robert E. Hawkins and Grazyna Lipowska‐Bhalla and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Eleanor J. Cheadle

35 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

2014 974 citations Simon J. Dovedi, Amy L. Adlard et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eleanor J. Cheadle United Kingdom	22	2.1k	1.2k	494	439	369	35	2.7k
Marka R. Crittenden United States	37	2.8k 1.3×	2.4k 2.0×	583 1.2×	719 1.6×	216 0.6×	106	4.0k
Christopher R. Heery United States	32	2.5k 1.2×	1.7k 1.4×	854 1.7×	876 2.0×	151 0.4×	112	3.8k
Emilian Racila United States	21	839 0.4×	712 0.6×	318 0.6×	436 1.0×	274 0.7×	45	2.0k
Jamie Honeychurch United Kingdom	21	1.9k 0.9×	1.4k 1.2×	639 1.3×	396 0.9×	196 0.5×	53	2.9k
Ainhoa Arina United States	28	2.3k 1.1×	2.7k 2.3×	486 1.0×	1.1k 2.5×	277 0.8×	50	4.2k
Joshua Brody United States	35	2.8k 1.4×	3.0k 2.6×	267 0.5×	1.1k 2.5×	525 1.4×	147	4.9k
Johanna Olweus Norway	26	1.5k 0.7×	1.8k 1.5×	241 0.5×	1.3k 3.0×	134 0.4×	61	3.9k
Wayne R. Godfrey United States	18	1.4k 0.7×	1.8k 1.5×	497 1.0×	1.0k 2.3×	88 0.2×	45	3.6k
Eric R. Lutz United States	15	2.6k 1.3×	2.3k 1.9×	298 0.6×	673 1.5×	130 0.4×	37	3.5k
Paul Zajac Switzerland	27	1.1k 0.6×	1.1k 1.0×	169 0.3×	654 1.5×	286 0.8×	57	2.4k

Countries citing papers authored by Eleanor J. Cheadle

Since Specialization

Citations

This map shows the geographic impact of Eleanor J. Cheadle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor J. Cheadle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor J. Cheadle more than expected).

Fields of papers citing papers by Eleanor J. Cheadle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleanor J. Cheadle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor J. Cheadle. The network helps show where Eleanor J. Cheadle may publish in the future.

Co-authorship network of co-authors of Eleanor J. Cheadle

This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor J. Cheadle. A scholar is included among the top collaborators of Eleanor J. Cheadle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor J. Cheadle. Eleanor J. Cheadle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Philip N., Tetyana Klymenko, Christian Klein, et al.. (2023). Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies. Frontiers in Cell and Developmental Biology. 11. 1270398–1270398. 2 indexed citations

Mukherjee, Debayan, Erminia Romano, Leo Zeef, et al.. (2023). Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1. OncoImmunology. 12(1). 2223094–2223094. 11 indexed citations

Price, James, Hitesh Mistry, Guy Betts, et al.. (2022). Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer. Journal of Clinical Oncology. 40(20). 2203–2212. 16 indexed citations

Cheadle, Eleanor J., et al.. (2020). Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations. Radiation Oncology. 15(1). 254–254. 68 indexed citations

Cazaux, Marine, Capucine L. Grandjean, Fabrice Lemaı̂tre, et al.. (2019). Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity. The Journal of Experimental Medicine. 216(5). 1038–1049. 93 indexed citations

Owens, G, et al.. (2018). Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells. Cancer Immunology Immunotherapy. 67(10). 1519–1531. 18 indexed citations

Dovedi, Simon J., Eleanor J. Cheadle, Edmund Poon, et al.. (2017). Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade. Clinical Cancer Research. 23(18). 5514–5526. 263 indexed citations

Dovedi, Simon J., Grazyna Lipowska‐Bhalla, Stephen A. Beers, et al.. (2016). Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells. Cancer Immunology Research. 4(7). 621–630. 44 indexed citations

Dovedi, Simon J., Amy L. Adlard, Grazyna Lipowska‐Bhalla, et al.. (2014). Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade. Cancer Research. 74(19). 5458–5468. 974 indexed citations breakdown →

10.

Guest, Ryan D., Н. А. Кириллова, Hannah Gornall, et al.. (2013). Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial. Cancer Immunology Immunotherapy. 63(2). 133–145. 17 indexed citations

11.

Cheadle, Eleanor J., Andreas Hombach, Markus Chmielewski, et al.. (2012). Chimeric Antigen Receptors for T-Cell Based Therapy. Methods in molecular biology. 907. 645–666. 36 indexed citations

12.

Honeychurch, Jamie, Waleed Alduaij, Eleanor J. Cheadle, et al.. (2012). Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway. Blood. 119(15). 3523–3533. 89 indexed citations

13.

Alduaij, Waleed, Andrei Ivanov, Jamie Honeychurch, et al.. (2011). Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood. 117(17). 4519–4529. 222 indexed citations

14.

Cheadle, Eleanor J., et al.. (2010). Natural Expression of the CD19 Antigen Impacts the Long-Term Engraftment but Not Antitumor Activity of CD19-Specific Engineered T Cells. The Journal of Immunology. 184(4). 1885–1896. 61 indexed citations

15.

Cheadle, Eleanor J., et al.. (2009). Eradication of Established B-cell Lymphoma by CD19-specific Murine T Cells is Dependent on Host Lymphopenic Environment and Can be Mediated by CD4+ and CD8+ T Cells. Journal of Immunotherapy. 32(3). 207–218. 26 indexed citations

16.

Armstrong, Anne, Eleanor J. Cheadle, & Robert E. Hawkins. (2005). Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma. BioDrugs. 19(5). 289–297. 2 indexed citations

17.

Cheadle, Eleanor J., David E. Gilham, Fiona Thistlethwaite, John Radford, & Robert E. Hawkins. (2005). Killing of non‐Hodgkin lymphoma cells by autologous CD19 engineered T cells. British Journal of Haematology. 129(3). 322–332. 17 indexed citations

18.

Guest, Ryan D., Robert E. Hawkins, Н. А. Кириллова, et al.. (2005). The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors. Journal of Immunotherapy. 28(3). 203–211. 255 indexed citations

19.

Cheadle, Eleanor J. & Andrew M. Jackson. (2002). Bugs as drugs for cancer. Immunology. 107(1). 10–19. 18 indexed citations

20.

Radford, Kristen J., Darren E. Higgins, Susanna Pasquini, et al.. (2002). A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy. 9(21). 1455–1463. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact